Clinical Trials Browser

Imatinib Mesylate × Head & Neck × 1 year × Clear all

NCT05816785 2025-09-03

Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Phase EARLY_PHASE1 Active not recruiting

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT03469011 2025-06-27

A Study to Try to Bring Back Radioiodine Sensitivity in Patients With Advanced Thyroid Cancer.

Phase 1 Terminated

EndocrineHead & Neck

Thyroid Cancer, Papillary